Qube Research & Technologies LTD Alpha Teknova, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Alpha Teknova, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 27 shares of TKNO stock, worth $137. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27
Previous 16,495
99.84%
Holding current value
$137
Previous $43,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TKNO
# of Institutions
31Shares Held
6.16MCall Options Held
0Put Options Held
0-
Israel Englander Millennium Management LLC | New York, Ny1.85MShares$9.44 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.05MShares$5.34 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA553KShares$2.83 Million0.0% of portfolio
-
Platinum Investment Management LTD Sydney Australia 2000, C3531KShares$2.72 Million0.03% of portfolio
-
Conestoga Capital Advisors, LLC454KShares$2.32 Million0.01% of portfolio
About Alpha Teknova, Inc.
- Ticker TKNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 28,080,500
- Market Cap $143M
- Description
- Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...